Saudi Arabia's Food and Drug Authority grants conditional approval for Anktiva, a new cancer therapy for advanced lung and ...
Not only can this cause dryness and discomfort, but the urethra sometimes doesn’t seal properly, and bacteria can get into ...
Not only can this cause dryness and discomfort, the urethra sometimes doesn’t seal properly, and bacteria can get into the ...
Shares surged 30% Thursday after reporting 700% Anktiva revenue growth and securing Saudi FDA approvals for lung and bladder ...
Not only can this cause dryness and discomfort, the urethra sometimes doesn't seal properly, and bacteria can get into the ...
If you have metastatic bladder cancer, you may also be at higher risk for kidney problems, including acute kidney injuries ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
ImmunityBio (IBRX) stock rises as the company records over 400% YoY groiwth in Q4 net product revenue thanks to its cancer ...
In a recent column, you wrote that hormone replacement therapy should be considered in elderly women to prevent urinary tract ...
ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary ...
Explosive Anktiva sales, new cancer data, and fresh approvals are rapidly redefining this immunotherapy story, today, Jan. 16 ...
The 2026 amendment introduces detailed metrological, technical, and safety standards for non-automated blood pressure devices ...